Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

SLV-154 Treatment of Metastatic Solid Tumors

This is a Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of SLV-154 across a range of dose levels when administered to subjects with metastatic solid tumors.

Participants needed: 70
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Solve TherapeuticsUpdated: Jun 30, 2026Locations: 10
Eligibility criteria

Men or women (as appropriate for cancer type) of age ≥18 years. [+27]

Malignancy involving the central nervous system unless brain metastases have bee... [+10]

Status: Recruiting

SLV-324 Treatment of Metastatic Solid Tumors

This is a Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of SLV-324 across a range of dose levels when administered to subjects with metastatic solid tumors.

Participants needed: 70
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Solve TherapeuticsUpdated: Feb 23, 2026Locations: 7
Eligibility criteria

Men or women (as appropriate for cancer type) of age ≥18 years. [+18]

Malignancy involving the central nervous system unless brain metastases have bee... [+10]